Main

Blood pressure measuring equipment in the dental surgery: use or ornament? M. Greenwood and R. J. Lowry Br Dent J 2002; 193: 273–275

Comment

Essential hypertension affects as many as 20% of the middle aged population the UK. Insurance companies were the first to note that a reduced lifespan was associated with the recording of high blood pressure. The subject of the paper by Greenwood and Lowry therefore has wide implications. The research objectives are several: to survey the knowledge and practice of GDPs; to seek their opinion as to the value of further education about hypertension; and to seek their opinion as to the value of hypertension screening by GDPs undertaking routine patient blood pressure (BP) measurement.

Postal questionnaires were returned by 207 (69%) GDPs. It was gratifying to note that a large proportion of the sample had a reasonable knowledge of both hypertension and antihypertensive drugs. Nearly all had received BP measurement training and enquired about the possibility of hypertension when checking the patients' medical history. About a third had sphygmomanometers.

The authors note that only about 5% of GDPs routinely measured their patients BP, but I was surprised that this was so high as this is not seen to be part of the GDP's usual role in the UK. Also, as was pointed out, this sample consisted of NHS practitioners and there is no fee payable for this investigation. The majority of those practicing conscious sedation techniques (about 41%) did measure BP as part of the patients' assessment.

GDPs may be well placed to screen for hypertension but is this part of their role? This paper introduces this interesting debate and sites the US literature where this debate is not new. Further research and debate together with cost benefit analyses would be required before hypertension screening by GDPs could be considered. One point raised by the authors is that of 'white coat hypertension'. Some patients have a marked stress reaction when seeing a healthcare professional and this may actually be of more concern when attending the GDP rather than the GMP. Other issues would have to be considered such as possible selection of special groups for screening. We know that high systolic pressure is more common in old age and that therapy reduces the risk of stroke and myocardial infarction. Urban black populations have higher incidence of hypertension than their white neighbours. Stroke is the most common complication amongst black hypertensives and myocardial infarction is relatively rare; the opposite is the case for white hypertensives.

Whilst the GDPs in this sample did think it was of value to have further education regarding hypertension, they questioned the value of their involvement in a screening programme.